XML 31 R21.htm IDEA: XBRL DOCUMENT
v3.25.3

NET SALES (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Revenue from Contract with Customer [Abstract] |
SCHEDULE OF NET SALES BY MARKET | The following tables summarize our net sales by market for the three and nine months ended September 30, 2025 and 2024, respectively: SCHEDULE OF NET SALES BY MARKET
|  | Product/ Service Transferred Over Time |  |  | Product Transferred at Point in Time |  |  | Noncash Consideration1 |  |  | Total Net Sales by Market |
|  | Three Months Ended September 30, 2025 |
|  | Product/ Service Transferred Over Time |  |  | Product Transferred at Point in Time |  |  | Noncash Consideration1 |  |  | Total Net Sales by Market |
Medical Device |  | $ | 5,758 |  |  | $ | 2,004 |  |  | $ | 589 |  |  | $ | 8,351 |
Medical Imaging |  |  | 8,215 |  |  |  | 2,169 |  |  |  | 5 |  |  |  | 10,389 |
Industrial |  |  | 6,163 |  |  |  | 1,798 |  |  |  | 251 |  |  |  | 8,212 |
Aerospace and Defense |  |  | 2,576 |  |  |  | 886 |  |  |  | 68 |  |  |  | 3,530 |
Total net sales |  | $ | 22,712 |  |  | $ | 6,857 |  |  | $ | 913 |  |  | $ | 30,482 |
|  | Product/ Service Transferred Over Time |  |  | Product Transferred at Point in Time |  |  | Noncash Consideration1 |  |  | Total Net Sales by Market |
|  | Three Months Ended September 30, 2024 |
|  | Product/ Service Transferred Over Time |  |  | Product Transferred at Point in Time |  |  | Noncash Consideration1 |  |  | Total Net Sales by Market |
Medical Device(2) |  | $ | 5,505 |  |  | $ | 2,087 |  |  | $ | 898 |  |  | $ | 8,490 |
Medical Imaging(2) |  |  | 7,206 |  |  |  | 2,348 |  |  |  | 3 |  |  |  | 9,557 |
Industrial |  |  | 5,505 |  |  |  | 2,667 |  |  |  | 262 |  |  |  | 8,434 |
Aerospace and Defense |  |  | 4,394 |  |  |  | 494 |  |  |  | 38 |  |  |  | 4,926 |
Total net sales |  | $ | 22,610 |  |  | $ | 7,596 |  |  | $ | 1,201 |  |  | $ | 31,407 |
|  | Product/ Service Transferred Over Time |  |  | Product Transferred at Point in Time |  |  | Noncash Consideration1 |  |  | Total Net Sales by Market |
|  | Nine Months Ended September 30, 2025 |
|  | Product/ Service Transferred Over Time |  |  | Product Transferred at Point in Time |  |  | Noncash Consideration1 |  |  | Total Net Sales by Market |
Medical Device |  | $ | 16,579 |  |  | $ | 5,738 |  |  | $ | 1,654 |  |  | $ | 23,971 |
Medical Imaging |  |  | 22,413 |  |  |  | 6,211 |  |  |  | 17 |  |  |  | 28,641 |
Industrial |  |  | 17,459 |  |  |  | 5,729 |  |  |  | 485 |  |  |  | 23,673 |
Aerospace and Defense |  |  | 9,333 |  |  |  | 2,250 |  |  |  | 184 |  |  |  | 11,767 |
Total net sales |  | $ | 65,784 |  |  | $ | 19,928 |  |  | $ | 2,340 |  |  | $ | 88,052 |
|  | Product/ Service Transferred Over Time |  |  | Product Transferred at Point in Time |  |  | Noncash Consideration1 |  |  | Total Net Sales by Market |
|  | Nine Months Ended September 30, 2024 |
|  | Product/ Service Transferred Over Time |  |  | Product Transferred at Point in Time |  |  | Noncash Consideration1 |  |  | Total Net Sales by Market |
Medical Device(2) |  | $ | 17,178 |  |  | $ | 6,919 |  |  | $ | 2,396 |  |  | $ | 26,493 |
Medical Imaging(2) |  |  | 20,291 |  |  |  | 7,193 |  |  |  | 14 |  |  |  | 27,498 |
Industrial |  |  | 18,847 |  |  |  | 7,682 |  |  |  | 1,114 |  |  |  | 27,643 |
Aerospace and Defense |  |  | 16,494 |  |  |  | 1,231 |  |  |  | 154 |  |  |  | 17,879 |
Total net sales |  | $ | 72,810 |  |  | $ | 23,025 |  |  | $ | 3,678 |  |  | $ | 99,513 |
1 | Noncash consideration represents material provided by the customer used in the manufacturing of the product.
2 | Medical, as reported in the prior-year period filing, has been split between Medical Device and Medical Imaging to conform with the current-year presentation.
SCHEDULE OF CONTRACT ASSETS | Contract assets, recorded in the condensed consolidated balance sheets, consist of unbilled amounts related to revenue recognized over time. Significant changes in the contract assets balance during the nine months ended September 30, 2025 were as follows: SCHEDULE OF CONTRACT ASSETS
Balance as of December 31, 2024 |  | $ | 13,792 |
Increase (decrease) attributed to: |  |  |  |
Amounts transferred over time to contract assets |  |  | 65,784 |
Allowance for current expected credit losses |  |  | (1 | )
Amounts invoiced during the period |  |  | (64,247 | )
Balance outstanding as of September 30, 2025 |  | $ | 15,328 |

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration